Ian Gauntt, RN, BSN, is the founder and editor of Peptide News Network, a Biosignal Media publication. A registered nurse with nearly a decade of critical care experience, he writes and edits the site's coverage of peptide research, clinical trials, and regulation, working from primary sources — peer-reviewed papers, trial registries, and FDA documents. His clinical background informs how the reporting reads the evidence, but Peptide News Network is a news and education publication, not a provider of individualized medical advice.
